Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Top 100 Creative Companies

- PMLiVE

Almirall acquires Allergan’s dermatology portfolio for $650m

The pharma group buys four products along with Allergan's first-in-class antibiotic Seysara

- PMLiVE

Boehringer and partners set sights on cystic fibrosis gene therapy

Deal builds on 17 years work in UK academic consortium

- PMLiVE

How pharma can unlock the potential of influencer marketing

Building a successful campaign around influencer marketing

- PMLiVE

Cancer immunotherapy: What’s on the horizon?

Old and new therapies

- PMLiVE

Ionis and Roche gain PRIME status for Huntingdon’s disease candidate

More good news for Ionis after first drug approval

- PMLiVE

Daily Brief: Cellectis gains Novartis scientist, EU label updates for Janssen and Otsuka

The latest from pharma, biotech and healthcare

- PMLiVE

Mallinckrodt doses first patient in muscular dystrophy trial

Repurposed drug could help delay decline in muscle function

- PMLiVE

China’s BeiGene raises $903m from Hong Kong IPO

Mammoth debut might have exceeded $1bn but for market jitters

- PMLiVE

Insights from Cannes Lions Health Festival 2018

Key learnings and trends

New ICMJE Guidelines and their Impact on Biotech

Currently, and over the past several years, I have enjoyed working with smaller biotechnology and pharma companies, many of which are looking to bring their first product to market. These...

Porterhouse Medical Group

- PMLiVE

Healthcare Comms round up

JOLT and The Ideas Foundation share talent fund, Ashfield opens new office and The Difference Collective offers charitable services

- PMLiVE

Daily Brief: Karuna raises $42m for novel CNS approach, Chen exits Roche, Orchard gains GSK board member

The latest from pharma, biotech and healthcare

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links